Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

transfers of value

- PMLiVE

Counting down to the EFPIA Disclosure Code

Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'

- PMLiVE

Could EFPIA’s new code boost pharma’s reputation?

Rule changes for payments to doctors could present the industry with an opportunity

ABPI London offices

Government crackdown on doctor-pharma payments

Physicians could face jail over accepting some industry gifts under new plans

Daiichi Sankyo logo

Daiichi Sankyo pays $39m in whistleblower case

Accused of paying US doctors to prescribe its drugs

- PMLiVE

The impact of the US Sunshine Act

A new dawn begins for pharma’s payments to doctors in the US

- PMLiVE

Counting value under the US Sunshine Act

International in scope, the implication of the transparency legislation are anything but clear

- PMLiVE

The changing regulatory environment

Code of practice changes are encouraging transparency in pharma/HCP relationships

ABPI London offices

Pharma paid £38.5m to UK healthcare professionals in 2013

Slight decrease on 2012 figures

- PMLiVE

Pharma payments to US doctors down

Follows intensified public scrutiny and introduction of the Sunshine Act

- PMLiVE

Pharma companies differ on Sunshine Act payment definition

Confusion about whether provision of editorial services is transfer of value

ABPI London offices

ABPI pledges greater payment transparency

UK pharma trade body updates Code of Practice

- PMLiVE

Public disclosure under the spotlight

With the final approval of the EFPIA Disclosure Code at the end of June and the implementation of the US Sunshine Act starting in August, transparency requirements and public disclosure...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links